BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03711578-completion@plaintrial.com
DTSTAMP:20261027T213544Z
DTSTART;VALUE=DATE:20201016
SUMMARY:Efficacy and Safety Study of Tenalisib (RP6530)\, a Novel PI3K δ/
 γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgki
 n's Lymphoma (iNHL) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03711578
URL:https://plaintrial.com/trial/NCT03711578
END:VEVENT
END:VCALENDAR